Suppr超能文献

相似文献

2
SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.
Nature. 2010 Jul 1;466(7302):138-42. doi: 10.1038/nature09140.
3
A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis.
Trends Cell Biol. 2013 Mar;23(3):135-40. doi: 10.1016/j.tcb.2012.10.011. Epub 2012 Nov 19.
4
Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
Mol Cancer Res. 2020 Jan;18(1):91-104. doi: 10.1158/1541-7786.MCR-19-0585. Epub 2019 Oct 24.
5
6
Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction.
Cancer Res. 2021 Apr 15;81(8):2128-2141. doi: 10.1158/0008-5472.CAN-20-2860. Epub 2021 Jan 28.
7
Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response.
J Biol Chem. 2009 Jul 3;284(27):18085-95. doi: 10.1074/jbc.M109.003020. Epub 2009 May 5.
8
ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.
Biochim Biophys Acta. 2016 Apr;1859(4):612-26. doi: 10.1016/j.bbagrm.2016.02.012. Epub 2016 Feb 24.
9
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.
Cancer Lett. 2024 Aug 1;596:216993. doi: 10.1016/j.canlet.2024.216993. Epub 2024 May 25.
10
P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
Oncotarget. 2017 Jun 20;8(25):41422-41431. doi: 10.18632/oncotarget.17440.

引用本文的文献

2
3
Structural mechanism for the recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F.
Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2501057122. doi: 10.1073/pnas.2501057122. Epub 2025 Jun 23.
4
Hepatocyte nuclear factor 4-Alpha: a key regulator in liver carcinogenesis.
Cell Oncol (Dordr). 2025 Aug;48(4):885-897. doi: 10.1007/s13402-025-01064-7. Epub 2025 May 20.
5
The Molecular Intersection of NEK1, C21ORF2, Cyclin F, and VCP in ALS Pathogenesis.
Genes (Basel). 2025 Mar 30;16(4):407. doi: 10.3390/genes16040407.
7
RRM2B deficiency causes dATP and dGTP depletion through enhanced degradation and slower synthesis.
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2503531122. doi: 10.1073/pnas.2503531122. Epub 2025 Apr 17.
10
RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress.
Cancer Gene Ther. 2025 May;32(5):550-562. doi: 10.1038/s41417-025-00895-8. Epub 2025 Mar 28.

本文引用的文献

1
Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation.
Oncogene. 2012 Sep 6;31(36):4076-84. doi: 10.1038/onc.2011.585. Epub 2011 Dec 19.
2
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.
Nature. 2012 Jan 5;481(7379):90-3. doi: 10.1038/nature10688.
3
Global identification of modular cullin-RING ligase substrates.
Cell. 2011 Oct 14;147(2):459-74. doi: 10.1016/j.cell.2011.09.019. Epub 2011 Sep 29.
5
Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.
Biochem Biophys Res Commun. 2011 Jun 24;410(1):102-7. doi: 10.1016/j.bbrc.2011.05.114. Epub 2011 May 25.
6
Nucleotide deficiency promotes genomic instability in early stages of cancer development.
Cell. 2011 Apr 29;145(3):435-46. doi: 10.1016/j.cell.2011.03.044.
8
Identification of early molecular markers for breast cancer.
Mol Cancer. 2011 Feb 11;10(1):15. doi: 10.1186/1476-4598-10-15.
10
Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
Hum Pathol. 2010 Dec;41(12):1742-8. doi: 10.1016/j.humpath.2010.06.001. Epub 2010 Sep 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验